SARS-CoV-2 Vaccines and the Skin

Galván Casas, Cristina; Català, A.; Muñoz Santos, Carlos

dc.contributor	Hospital General de Granollers
dc.contributor.author	Galván Casas, Cristina
dc.contributor.author	Català, A.
dc.contributor.author	Muñoz Santos, Carlos
dc.date.accessioned	2022-03-18T08:56:47Z
dc.date.available	2022-03-18T08:56:47Z
dc.date.issued	2021-10-01
dc.identifier.citation	Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr. 2021 Oct;112(9):828-836.
dc.identifier.issn	0001-7310
dc.identifier.uri	https://hdl.handle.net/11351/7206
dc.description	Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reaccions cutànies; Vacunes
dc.language.iso	eng
dc.publisher	Elsevier España
dc.relation.ispartofseries	Actas dermo-sifiliográficas;112(9)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	COVID-19 (Malaltia)
dc.subject	Vacunes
dc.subject	Pell - Malalties
dc.subject.mesh	Vaccines
dc.subject.mesh	Skin Manifestations
dc.subject.mesh	Coronavirus Infections
dc.title	SARS-CoV-2 Vaccines and the Skin
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.adengl.2021.07.028
dc.subject.decs	vacunas
dc.subject.decs	manifestaciones cutáneas
dc.subject.decs	infecciones por Coronavirus
dc.relation.publishversion	https://doi.org/10.1016/j.adengl.2021.07.028
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.authoraffiliation	[Galván-Casas C] Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain. [Català A] Servicio de Dermatología, Sede Plató, Hospital Clínic, Barcelona, Spain. [Muñoz-Santos C] Servicio de Dermatología, Hospital General de Granollers, Granollers, Spain
dc.identifier.pmid	34483343
dc.rights.accessrights	info:eu-repo/semantics/openAccess